Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 135

Century Therapeutics submits IPO filing

Bayer and Fujifilm could exit the oncology therapy developer through an initial public offering with a $100m placeholder target.

Jun 2, 2021

Daily Deal Round Up: June 1, 2021

Oriola sold part of its stake in telehealth platform developer Doktor.se through a $61.1m round while bicycle marketplace The Pro’s Closet bagged $40m.

Jun 1, 2021

Centessa captures $330m in IPO

Centessa, formed earlier this year through a ten-way merger involving multiple spinouts, has completed a listing in the US.

Jun 1, 2021

Ada Health adds $90m

The health assessment software provider secured the funding in a series B round led by Bayer that also featured Samsung Catalyst Fund.

Jun 1, 2021

Binx links to $104m in series E round

Johnson & Johnson’s investment arm has returned to back the molecular diagnostic technology developer, which also counts Novartis, Consort Medical and Wondfo Biotech as investors.

Jun 1, 2021

Daily deal net: May 31, 2021

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

May 31, 2021

Daily Deal Round Up: May 28, 2021

Lilly Asia Ventures took part in a $78m round for oncology therapy developer BH Med while gifting platform developer Snappy completed a $70m Hearst-backed series C.

May 28, 2021

Daily deal net: May 28, 2021

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

May 28, 2021

Sub-sector: care provision and on demand services

The gamification of life continues, just updated for the modern world it seems.

May 28, 2021

Day One begins $160m IPO

Access Industries and Takeda scored exits as the oncology therapy developer floated at the top of its range in an upsized offering.

May 28, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here